NDC product
Rosuvastatin Calcium
NDC 60290-043 · Umedica Laboratories USA Inc.
Key facts
| Product NDC | 60290-043 |
|---|---|
| Proprietary name | Rosuvastatin Calcium |
| Nonproprietary name | Rosuvastatin Calcium |
| Substances | ROSUVASTATIN CALCIUM |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Umedica Laboratories USA Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA207626 |
| Pharmacologic classes | HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| Marketing start | Nov 30, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: